Developing lenabasum for the treatment of rare, chronic and serious inflammatory and fibrotic diseases.
Visit Website
Read our latest news
© 2018 DVI EQUITY PARTNERS a Diamond Ventures Company. All rights reserved. Privacy PolicySitemapWebsite by Caliber Group
